• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中炎症与纤维化交叉点上的代谢

Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease.

作者信息

Miguel Verónica, Shaw Isaac W, Kramann Rafael

机构信息

Department of Medicine 2, Nephrology, Rheumatology and Immunology, RWTH Aachen University, Medical Faculty, Aachen, Germany.

Department of Internal Medicine, Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

Nat Rev Nephrol. 2025 Jan;21(1):39-56. doi: 10.1038/s41581-024-00889-z. Epub 2024 Sep 17.

DOI:10.1038/s41581-024-00889-z
PMID:39289568
Abstract

Chronic kidney disease (CKD), defined as persistent (>3 months) kidney functional loss, has a growing prevalence (>10% worldwide population) and limited treatment options. Fibrosis driven by the aberrant accumulation of extracellular matrix is the final common pathway of nearly all types of chronic repetitive injury in the kidney and is considered a hallmark of CKD. Myofibroblasts are key extracellular matrix-producing cells that are activated by crosstalk between damaged tubules and immune cells. Emerging evidence indicates that metabolic alterations are crucial contributors to the pathogenesis of kidney fibrosis by affecting cellular bioenergetics and metabolite signalling. Immune cell functions are intricately connected to their metabolic characteristics, and kidney cells seem to undergo cell-type-specific metabolic shifts in response to damage, all of which can determine injury and repair responses in CKD. A detailed understanding of the heterogeneity in metabolic reprogramming of different kidney cellular subsets is essential to elucidating communication processes between cell types and to enabling the development of metabolism-based innovative therapeutic strategies against CKD.

摘要

慢性肾脏病(CKD)定义为持续性(>3个月)肾功能丧失,其患病率不断上升(全球人口>10%)且治疗选择有限。由细胞外基质异常积聚驱动的纤维化是肾脏几乎所有类型慢性重复性损伤的最终共同途径,被认为是CKD的一个标志。肌成纤维细胞是产生细胞外基质的关键细胞,通过受损肾小管与免疫细胞之间的相互作用而被激活。新出现的证据表明,代谢改变通过影响细胞生物能量学和代谢物信号传导,是肾脏纤维化发病机制的关键因素。免疫细胞功能与其代谢特征密切相关,肾脏细胞似乎会因损伤而发生细胞类型特异性的代谢转变,所有这些都可以决定CKD中的损伤和修复反应。详细了解不同肾脏细胞亚群代谢重编程的异质性,对于阐明细胞类型之间的通讯过程以及开发基于代谢的针对CKD的创新治疗策略至关重要。

相似文献

1
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease.慢性肾脏病中炎症与纤维化交叉点上的代谢
Nat Rev Nephrol. 2025 Jan;21(1):39-56. doi: 10.1038/s41581-024-00889-z. Epub 2024 Sep 17.
2
Origin of myofibroblasts and cellular events triggering fibrosis.肌成纤维细胞的起源和触发纤维化的细胞事件。
Kidney Int. 2015 Feb;87(2):297-307. doi: 10.1038/ki.2014.287. Epub 2014 Aug 27.
3
Metabolic reprogramming heterogeneity in chronic kidney disease.慢性肾脏病中的代谢重编程异质性。
FEBS Open Bio. 2023 Jul;13(7):1154-1163. doi: 10.1002/2211-5463.13568. Epub 2023 Feb 14.
4
The cellular and signalling alterations conducted by TGF-β contributing to renal fibrosis.转化生长因子-β(TGF-β)所引发的细胞及信号改变会导致肾纤维化。
Cytokine. 2016 Dec;88:115-125. doi: 10.1016/j.cyto.2016.08.019. Epub 2016 Sep 4.
5
Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis.细胞外基质成分与肾脏纤维化中的细胞及分子机制之间的相互作用
Clin Sci (Lond). 2021 Aug 27;135(16):1999-2029. doi: 10.1042/CS20201016.
6
IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury.IRF-4 缺乏可减少叶酸诱导的急性肾损伤后的炎症和肾纤维化。
Int Immunopharmacol. 2021 Nov;100:108142. doi: 10.1016/j.intimp.2021.108142. Epub 2021 Sep 20.
7
Renal fibrosis: Primacy of the proximal tubule.肾纤维化:近端小管的首要地位。
Matrix Biol. 2018 Aug;68-69:248-262. doi: 10.1016/j.matbio.2018.02.006. Epub 2018 Feb 6.
8
The Mechanism of CD8 T Cells for Reducing Myofibroblasts Accumulation during Renal Fibrosis.CD8 T 细胞减少肾纤维化过程中肌成纤维细胞积累的机制。
Biomolecules. 2021 Jul 5;11(7):990. doi: 10.3390/biom11070990.
9
Metabolism and bioenergetics in the pathophysiology of organ fibrosis.器官纤维化病理生理学中的代谢和生物能量学。
Free Radic Biol Med. 2024 Sep;222:85-105. doi: 10.1016/j.freeradbiomed.2024.06.001. Epub 2024 Jun 3.
10
New tools to study renal fibrogenesis.研究肾纤维化的新工具。
Curr Opin Nephrol Hypertens. 2024 Jul 1;33(4):420-426. doi: 10.1097/MNH.0000000000000988. Epub 2024 Apr 8.

引用本文的文献

1
Comparative performance of multiple inflammatory indices across different stages of cardiovascular-kidney-metabolism syndrome: A Multi-Cohort Study.心血管-肾脏-代谢综合征不同阶段多种炎症指标的比较性能:一项多队列研究。
Endocrine. 2025 Aug 18. doi: 10.1007/s12020-025-04390-w.
2
A comprehensive review on computational metabolomics: Advancing multiscale analysis through approaches.关于计算代谢组学的全面综述:通过多种方法推进多尺度分析。
Comput Struct Biotechnol J. 2025 Jul 13;27:3191-3215. doi: 10.1016/j.csbj.2025.07.016. eCollection 2025.
3
High-mobility group box 1 in acute kidney injury.

本文引用的文献

1
Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression.单细胞多组学和空间分析揭示了人类肾脏纤维化微环境在肾脏疾病进展中的作用。
Nat Genet. 2024 Aug;56(8):1712-1724. doi: 10.1038/s41588-024-01802-x. Epub 2024 Jul 24.
2
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.司美格鲁肽对 2 型糖尿病患者慢性肾脏病的影响。
N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24.
3
Tubular CPT1A deletion minimally affects aging and chronic kidney injury.
急性肾损伤中的高迁移率族蛋白B1
Front Pharmacol. 2025 Jul 14;16:1618971. doi: 10.3389/fphar.2025.1618971. eCollection 2025.
4
Prognostic implications of systemic immune-inflammation index and systemic inflammation response index in hemodialysis patients.血液透析患者全身免疫炎症指数和全身炎症反应指数的预后意义
BMC Nephrol. 2025 Jul 1;26(1):322. doi: 10.1186/s12882-025-04223-y.
5
Lactate and lactylation in the kidneys: Current advances and prospects (Review).肾脏中的乳酸与乳酸化:当前进展与展望(综述)
Int J Mol Med. 2025 Aug;56(2). doi: 10.3892/ijmm.2025.5562. Epub 2025 Jun 6.
6
Identification and validation of inflammatory response genes linking chronic kidney disease with coronary artery disease based on bioinformatics and machine learning.基于生物信息学和机器学习的慢性肾脏病与冠状动脉疾病相关炎症反应基因的鉴定与验证
Sci Rep. 2025 Jun 1;15(1):19184. doi: 10.1038/s41598-025-03622-3.
7
How the Renal Tubule May Adapt to Fuel Shortage.肾小管如何适应燃料短缺。
Kidney360. 2025 May 1;6(5):677-679. doi: 10.34067/KID.0000000826.
8
Multiplatform Metabolomic Profiling of the Unilateral Ureteral Obstruction Murine Model of CKD.慢性肾脏病单侧输尿管梗阻小鼠模型的多平台代谢组学分析
Int J Mol Sci. 2025 May 21;26(10):4933. doi: 10.3390/ijms26104933.
9
Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies.靶向脂质代谢重编程以减轻糖尿病肾病:分子见解与治疗策略
Front Immunol. 2025 Apr 25;16:1549484. doi: 10.3389/fimmu.2025.1549484. eCollection 2025.
10
Extracellular Vesicles in Renal Inflammatory Diseases: Revealing Mechanisms of Extracellular Vesicle-Mediated Macrophage Regulation.肾脏炎症性疾病中的细胞外囊泡:揭示细胞外囊泡介导的巨噬细胞调节机制
Int J Mol Sci. 2025 Apr 12;26(8):3646. doi: 10.3390/ijms26083646.
管状 CPT1A 缺失对衰老和慢性肾脏损伤的影响最小。
JCI Insight. 2024 Feb 22;9(6):e171961. doi: 10.1172/jci.insight.171961.
4
WWP2 Regulates Renal Fibrosis and the Metabolic Reprogramming of Profibrotic Myofibroblasts.WWP2 调控肾纤维化和致纤维化肌成纤维细胞的代谢重编程。
J Am Soc Nephrol. 2024 Jun 1;35(6):696-718. doi: 10.1681/ASN.0000000000000328. Epub 2024 Mar 19.
5
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis.用于减轻肾纤维化的高效超长效胰高血糖素样肽-1和胰高血糖素共激动剂的设计与发现
Acta Pharm Sin B. 2024 Mar;14(3):1283-1301. doi: 10.1016/j.apsb.2023.11.020. Epub 2023 Nov 18.
6
Inhibition of PFKP in renal tubular epithelial cell restrains TGF-β induced glycolysis and renal fibrosis.抑制肾小管上皮细胞中的 PFKP 可抑制 TGF-β 诱导的糖酵解和肾纤维化。
Cell Death Dis. 2023 Dec 12;14(12):816. doi: 10.1038/s41419-023-06347-1.
7
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1-3a CKD patients.生酮饮食对慢性肾脏病患者体重减轻的影响:一项针对肥胖的1-3a期慢性肾脏病患者的随机对照试验。
Clin Kidney J. 2023 Jul 18;16(12):2309-2313. doi: 10.1093/ckj/sfad176. eCollection 2023 Dec.
8
Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney.通过二甲双胍和黄芩苷增强脂肪酸氧化治疗 COVID-19 及肺部和肾脏相关炎症状态。
Redox Biol. 2023 Dec;68:102957. doi: 10.1016/j.redox.2023.102957. Epub 2023 Nov 3.
9
FLOW trial stopped early due to evidence of renal protection with semaglutide.由于司美格鲁肽具有肾脏保护作用的证据,FLOW试验提前终止。
Eur Heart J Cardiovasc Pharmacother. 2024 Jan 5;10(1):7-9. doi: 10.1093/ehjcvp/pvad080.
10
Palmitoyltransferase DHHC9 and acyl protein thioesterase APT1 modulate renal fibrosis through regulating β-catenin palmitoylation.棕榈酰基转移酶 DHHC9 和酰基蛋白硫酯酶 APT1 通过调节β-连环蛋白棕榈酰化调节肾纤维化。
Nat Commun. 2023 Oct 21;14(1):6682. doi: 10.1038/s41467-023-42476-z.